Pro-Atherogenic Oxidized Ldl/β2-Glycoprotein I Complexes in Diabetes Mellitus: Antioxidant Effect of Statins-Juniper Publishers

JUNIPER PUBLISHERS-OPEN ACCESS JOURNAL OF CARDIOLOGY & CARDIOVASCULAR THERAPY Abstract Premature atherosclerotic cardiovascular disease (CVD) is a well known complication of diabetes mellitus (DM) associated with significant morbidity and mortality. The development of atherosclerosis is largely promoted by oxidative stress and chronic inflammation. Elevated low-density lipoprotein (LDL) is a known atherosclerotic risk factor but LDL must be modified to become atherogenic. Inflammatory-derived reactive oxygen and nitrogen species oxidize LDL (oxLDL) giving rise to lipid peroxides and aldehydes that favor the initiation and progression of atherosclerotic lesions. Beta-2-glycoprotein I (β2GPI) is a lipid binding plasma protein with pleiotropic functions that binds oxLDL via specific oxidative-derived ligands to form pro-atherogenic oxLDL/β2GPI complexes and in this guise exerts a buffering effect upon LDL oxidation. Statin (Rosuvastatin) treatment lowered serum le...